Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Emergent Bio gets FDA green light for mpox vaccine
Pharmaphorum
Friday, August 30, 2024 - 11:18am
tags:
Emergent BioSolutions, FDA, vaccines, mpox, ACAM2000
Novartis and Genentech’s Xolair is rising rapidly on TV
Medical Marketing and Media
Thursday, August 29, 2024 - 6:11pm
tags:
Novartis, Genentech, Xolair, television ads
FDA's drug center to consolidate AI efforts under single council
Fierce Biotech
Thursday, August 29, 2024 - 6:10pm
tags:
FDA, CDER, regulatory, artificial intelligence
SCOTUS overturn of Chevron doctrine opens a Pandora's box for biopharma industry, expert says
Fierce Pharma
Thursday, August 29, 2024 - 6:08pm
tags:
SCOTUS, Supreme Court, Chevron Doctrine
WHO invites makers of mpox tests for emergency review in push for rapid access
Reuters
Thursday, August 29, 2024 - 6:07pm
tags:
WHO, mpox, diagnostics, Roche, LabCorp
AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study
Fierce Pharma
Thursday, August 29, 2024 - 6:06pm
tags:
AbbVie, Ubrelvy, migraines, clinical trials
J&J submits touted autoimmune disease drug for FDA approval
BioPharma Dive
Thursday, August 29, 2024 - 11:24am
tags:
JNJ, myasthenia gravis, FDA, nipocalimab
Cell and gene therapy investment, once booming, is now in a slump
BioPharma Dive
Thursday, August 29, 2024 - 11:22am
tags:
cell therapy, gene therapy, investors
BioMarin cuts deeper with 225 layoffs under CEO's new corporate strategy
Fierce Pharma
Thursday, August 29, 2024 - 11:18am
tags:
Biomarin, layoffs
Merck’s Keytruda flunks pivotal studies in early-stage lung and skin cancers
Fierce Pharma
Thursday, August 29, 2024 - 11:15am
tags:
Merck, Keytruda, non-small cell lung cancer, clinical trials, cutaneous squamous cell carcinoma
FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic
Clinical Trials Arena
Thursday, August 29, 2024 - 11:13am
tags:
Life Molecular Imaging, PET imaging, PI-2620, Medtech
‘More siloed than ever’: Pharma’s deep digital disconnect
Medical Marketing and Media
Thursday, August 29, 2024 - 11:12am
tags:
digital pharma, omnichannel
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Motley Fool
Thursday, August 29, 2024 - 11:10am
tags:
IPOs, Artiva, autoimmune diseases, cell therapy, AlloNK
Gain hopes to prove Parkinson's drug's potential next year after phase 1 win for allosteric modulator
Fierce Biotech
Thursday, August 29, 2024 - 11:08am
tags:
Gain Therapeutics, Parkinson's Disease, clinical trials, GT-02287
As pharma’s AI revolution gets underway, ‘hallucinations’ pose a great risk
Pharma Voice
Thursday, August 29, 2024 - 11:07am
tags:
artificial intelligence
Their Alzheimer’s treatment worked — but shares fell anyway
Pharma Voice
Thursday, August 29, 2024 - 11:06am
tags:
Cognition Therapeutics, clinical trials, Alzheimer's disease, CT1812
GSK gets EU okay for RSV shot in younger age group
Pharmaphorum
Thursday, August 29, 2024 - 11:05am
tags:
GSK, Europe, vaccines, RSV, Arexvy
Eli Lilly’s lauded discount of its obesity drug Zepbound comes with caveats
Stat
Wednesday, August 28, 2024 - 9:24pm
tags:
Eli Lilly, Zepbound, DTC
House Oversight Chair challenges PBM leaders on alleged false statements
First Word Pharma
Wednesday, August 28, 2024 - 9:18pm
tags:
PBMs, CVS Caremark, Express Scripts, OptumRx
Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care
Medtech Dive
Wednesday, August 28, 2024 - 9:14pm
tags:
Medtech, Insulet, type 2 diabetes, insulin pumps

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.